-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Background: Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by a venous or arterial thromboembolic event or obstetric manifestation, with the persistence of at least one type of antiphospholipid antibody (aPL) (lupus anticoagulant, anticardiolipin antibody, or anti-beta2 glycoprotein 1 (anti-beta2GP1)
Methods: A retrospective multicenter study
Results: Including 30 patients (19 females), the median age was 40 years (34-52 years).
Conclusion: The renal prognosis of isolated APSN is poor, and 6 patients develop ESRD
Source: Rousselin C, Amoura Z, Faguer S, Bataille P, Boffa JJ, Canaud G, Guerrot D, Jourde-Chiche For The Gclr N, Karras A, Auxenfants E, Chapelet A, Lambert M, Behal H, Nochy D, Jean-Paul DVH, Brocheriou For The Cfpr I, Gnemmi V, Quemeneur T.